Midgard Science

BRC Biotechnology

Shanghai, China brcbiotech.com

From their website, Nov 2026

Work here? Claim this listing

About

BRC Biotechnology provides biosafety testing and quality control services for biopharmaceuticals. It works with antibody drugs, cell and gene therapy, recombinant proteins, vaccines, and nucleic acid drugs for clients supporting IND/BLA submissions. The company operates from Shanghai, China, and Cambridge, Massachusetts, USA.

Services

  • Antibody Product Testing

    Provides cell line characterization, viral clearance studies, unprocessed bulk testing, lot release testing, and genetic stability studies for antibody products such as mAb, ADC, and RDC.

  • Cell and Gene Therapy Testing

    Provides biosafety testing for viral vectors, oncolytic viruses, stem cells, CAR-T/TCR-T, CAR-NK, and TIL products, including viral seed characterization and detection of replication competent virus.

  • Recombinant Protein Testing

    Provides quality testing for recombinant protein products, including microbial bank characterization, unprocessed bulk and lot release testing, and genetic stability studies.

  • Vaccine Testing

    Provides biosafety testing for attenuated, inactive, and subunit vaccines, including microbial bank characterization, viral seed characterization, unprocessed bulk testing, and lot release testing.

  • Nucleic Acid Drug Testing

    Provides testing for mRNA and siRNA products, including microbial bank characterization, plasmid bulk harvest testing, and drug product lot release testing.

  • Rapid Testing

    Provides rapid testing platforms and kits including Celer Q Detection Kit and NGenius®.

  • Virology Testing

    Provides virology testing for porcine and bovine virus detection, exogenous viral factor contamination detection, infectious retrovirus detection, and replication-competent virus detection.

  • Viral Clearance Studies

    Provides viral clearance testing support for biologics development and regulatory submissions.

  • Animal Testing

    Provides animal testing capabilities as part of its biosafety platform.

Capabilities

Assays and studies
Antibodies · NGS · Cell therapy · qPCR · CHO · ADCs · Cell line characterization · Viral clearance · Unprocessed bulk testing · Lot release testing · Genetic stability studies · Microbial bank characterization
9 moreViral seed characterization · Detection of replication competent virus · Sterility · Mycoplasma testing · Adventitious virus testing · Retrovirus testing · Porcine virus detection · Bovine virus detection · Exogenous viral factor contamination detection
Scale and capacity
100+ global client audits passed · 100+ IND/BLA submission projects · 6000+ delivered tests · 600+ delivered projects · 40+ commercial projects · 60+ BLA projects

Instruments and platforms

  • NGenius® platform
  • Transmission Electron Microscopy (TEM)
  • PERT assay
  • qPCR
  • Targeted NGS
  • Sanger sequencing
  • Multiplex PCR

Modalities and species

Modalities
Antibody · ADC · Oligonucleotide · mRNA · Viral vector · Cell therapy · Recombinant protein · Vaccine · Plasmid DNA
Species and models
E. coli · CHO cells · HIV

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • FDA registrationListed in FDA database

    Listed in the FDA registration database as of Nov 2026

    Scope: FDA Establishment Identifier (FEI) · Issued by U.S. FDA · No. 3030103136

    FDA database

  • ISO 9001:2015Self-reported

  • GLPSelf-reported

Company

Type
Testing lab

Locations

Address
625 Mt Auburn Street, Suite 105 Cambridge, MA 02138
Sites
Shanghai, China
Serves
global

Public records

FDA establishment
3030103136

Similar labs

Work here? Claim this listing